Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Cohort studies have reported that midlife high total serum cholesterol (TC) is associated with increased risk of Alzheimer’s disease (AD) in late-life but findings have been based on few studies and previous reviews have been limited by a lack of compatible data. Objective: We synthesized all high quality data from cohort studies reporting on the association between total serum cholesterol measured and late-life cognitive outcomes including Alzheimer’s disease (AD), vascular dementia (VaD), any dementia, mild cognitive impairment (MCI), and cognitive decline. Methods: The literature was searched up to October 2016 using a registered protocol. Thirty-four articles meeting study criteria were identified. Seventeen studies published from 1996 to 2014, including 23,338 participants were included in meta-analyses. Results: Relative risk of developing AD for adults with high TC in midlife was 2.14 (95% CI 1.33–3.44) compared with normal cholesterol. Individual studies that could not be pooled also reported high TC in midlife increased the risk of MCI and cognitive decline in late-life. High TC in late-life was not associated with MCI, AD, VaD, any dementia, or cognitive decline. Late-life measured HDL cholesterol and triglycerides were not associated with increased risk of VaD, and HDL was not associated with risk of MCI, AD, or any dementia. There were insufficient data to examine other cholesterol sub-fractions, sex differences, or APOE interactions. Conclusions: Significant gaps in the literature regarding TC and late-life dementia remain. Evidence suggests that high midlife TC increases risk of late-life AD, and may correlate with the onset of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analytic evidence found inconsistent evidence from HICs that high LDL-C in midlife, but not in later life, might be a risk factor for cognitive decline, all cause dementia and AD.”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [151]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, midlife obesity, 105,111,112 hypertension, 85,[105][106][107] prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) 85 and high cholesterol 113 are associated with an increased risk of dementia in later life.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [113]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Systematic review evidence has shown there is no consistent evidence linking high cholesterol in midlife or late-life to risk of vascular dementia, and no consistent evidence linking high cholesterol in late-life to risk of AD (5).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“If there was evidence of heterogeneity and four or more studies were available, random effects meta-analysis was used [18, 19].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Heterogeneity among studies was examined using standard I2 which estimates the proportion of variance due to heterogeneity [16].”
MethodPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“MATERIALS AND METHODS Registration of protocol and reporting The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO CRD42015026727) [6] and reported in accordance with the PRISMA checklist [7].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 2×
“Additional quality ratings were conducted for all studies meeting criteria using a checklist adapted from previous reviews, and the Newcastle Ottawa scale [8, 9].”
BackgroundMethodBorenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 1×
“For clinical diagnosis of MCI, we accepted Petersen [13], Winblad [14], or other widely accepted clinical research criteria.”
MethodHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“However, studies publishing on midlife lacked clear information on the age range of the sample at baseline and the distribution of the sample within midlife and late-life [12, 21].”
Background
Research works printed but not linked: 4
- 2005, Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]
- Slooter AJC, 2000, Neurology, 54, 2357
- Liao PJ, 2015, Int J Clin Exp Med, 8, 19200
- McGuinness B, 2016, Cochrane Database Syst Rev, 1, CD003160
Cited by
Items 301–359 of 359
Involvement of cholesterol and β-amyloid in the initiation and progression of Alzheimer’s disease
Aguayo, L. G., Roa, J., Burgos, C. F., & González-Sanmiguel, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00039-0 · Cited by 1
Förstl, H., & Förstl, S. (2020) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_58-1 · Cited by 2
Ciric, J., Tešić, V., Milovanovic, N., Macura, I. J., Ivković, S., Kanazir, S., & Perović, M. (2022) · Brain Sciences · doi:10.3390/brainsci12101297
“A significant number of studies have also shown that elevated levels of serum lipids, in particular cholesterol, may be detrimental to human learning and memory [5,6].”
BackgroundXie, Y.-Y., Zhao, L., Gao, L., Xu, R., Gao, Y., Dou, K., Guo, Y., & He, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2127326/v1
Complementary Medications (Statins, Nicergoline, Naftidrofuryl) in Dementia
Yaman, A., & Yaman, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_422
Huda, N. N. (2023) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/2tjwz
Statins’ Effects on Alzheimer’s Disease
Li, Q., Li, C.-N., & Chen, J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001286 · Cited by 1
Late life vascular risk factors and their association with dementia and Alzheimer’s disease
Ibrahim, A. A., Haji, H. Y., & Hassan, A. M. (2022) · Journal of Geriatric Medicine · doi:10.30564/jgm.v4i1.4548
“The association between total cholesterol and risk of dementia seams to vary with age at measurement (mid-life [<65 years] or later life [≥65 years]) and follow-up duration ([44-49]).”
BackgroundZhang, C., Fan, H., & Li, M. (2023) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2023.12.123 · Cited by 2
APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice
Valencia‐Olvera, A. C., Balu, D., Moore, A., Shah, M., Ainis, R., Xiang, B., Saleh, Y., Cai, D., LaDu, M. J., & Tai, L. M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231210
Reliability of self-reported risk factors for age-related brain diseasePreprint
Tack, R. W. P., Senff, J. R., Kimball, T. N., Prapiadou, S., Yechoor, N., Rosand, J. M., Singh, S., & Anderson, C. D. (2024) · medRxiv · doi:10.1101/2024.04.25.24306370
“These models often include hypertension 10–12 , hypercholesterolemia 13–15 , diabetes 16,17 , kidney disease 18,19 , being overweight 20,21 , and hearing impairment 22–24 .”
BackgroundAkhanemhe, R., Stevelink, S. A. M., Corbett, A., Ballard, C. G., Brooker, H. J., Creese, B., Aarsland, D., Hampshire, A., & Greenberg, N. L. (2024) · Occupational Medicine · doi:10.1093/occmed/kqae027
“The relationship between diabetes, high cholesterol and MCI identified within the veteran sample aligns with previous research that explored this association in the general population [30,31].”
BackgroundResultHua, J., Dong, J., Chen, Y., Li, H., & Chen, Q. (2024) · medRxiv · doi:10.1101/2024.11.16.24317444
Reas, E. T., Parada, H., Bergstrom, J., & McEvoy, L. K. (2025) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbaf005
Lifestyle Medicine in Patient Care
Fagundes, C. P., Merlo, G., & Rippe, J. M. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640814.003.0015
Luo, C., Li, Q., Gao, R., Zhang, Y., Wang, Y., Huang, F., Li, Q., Zheng, X., Zhang, X., Liu, W., et al. (2025) · Current Alzheimer Research · doi:10.2174/0115672050370810250430112549
Multiple Sclerosis and Cholesterol Metabolism
Sarıdaş, F., Sarıdaş, F. M., Ersoy, C., & Turan, Ö. F. (2025) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1589812
“11-15”
Özdemir, F., Sağlam, M., Uyaroğlu, O. A., & Vardar‐Yağlı, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-02223-4
Associations of 35 Serum and Urine Biomarkers With Vascular Dementia—A Mendelian Randomization Study
Zhu, X., Hu, Y., Lin, J., Zhuo, G., Huang, Y., Fu, Y., Zhang, Y., Wu, L., & Chen, W. (2025) · Brain and Behavior · doi:10.1002/brb3.70736
Epidemiology and Risk Factors for Dementia
Dintica, C. S., & Yaffe, K. S. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.008
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615258
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615255
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615246
Zhang, H., Zhu, W., Niu, T., Wang, Z., An, K., Cao, W., Shi, J., & Wang, S. (2021) · Figshare · doi:10.6084/m9.figshare.16608931
Intake of Dietary Fats and Links and Associations with Cognitive Function
Bodenrader, A., & Bigornia, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_156-1
Xie, Y., Zhao, L., Gao, L.-J., Xu, R., Gao, Y., Dou, K.-F., Yuanlin, G., & He, Y.-M. (2022) · Figshare · doi:10.6084/m9.figshare.21559156
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615234
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678624
Liu, L., Zhang, C., XiaoZhen, L., Lai, X., Xu, L., Feng, J., Song, Y., Wang, S., & Zhan, S. (2020) · Figshare · doi:10.6084/m9.figshare.13346758
Wang, Q., Zang, F., He, C., Zhang, Z., & Xie, C. (2024) · Figshare · doi:10.6084/m9.figshare.26550850
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615243
Jeong, S. H., Chung, S. J., Yoo, H. S., Jung, J. H., Baik, J. S., Sohn, Y. H., & Lee, P. H. (2024) · Figshare · doi:10.6084/m9.figshare.25123992
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678603
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678600
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678612
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615249
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615237
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678621
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678618
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678609
Petek, B., Häbel, H., Xu, H., Villa‐Lopez, M., Kalar, I., Hoang, M. T., Maioli, S., Pereira, J. B., Mostafaei, S., Winblad, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24873040
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678606
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615252
Chang, H.-T., Chan, P.-C., & Chiu, P.-Y. (2024) · Figshare · doi:10.6084/m9.figshare.25940103
Pan, X., Luo, Y., Zhao, D., & Zhang, L. (2022) · Figshare · doi:10.6084/m9.figshare.20517113
Liu, P., Liu, J., Zhang, Y., Xing, X., Zhou, L., Qu, J., & Yan, X. (2024) · Figshare · doi:10.6084/m9.figshare.26678615
Gong, J., Harris, K., Peters, S. A. E., & Woodward, M. (2021) · Figshare · doi:10.6084/m9.figshare.14615240
Cardiovascular Risk Factors From Early Childhood and Cognitive Function in Young Adulthood
Salo, H., Pahkala, K., Niinikoski, H., Lagström, H., Salo, P., Jula, A., Ronnemaa, T., Viikari, J., Raitakari, O. T., & Rovio, S. (2026) · PEDIATRICS · doi:10.1542/peds.2025-071353 · Cited by 1
Lefèvre‐Arbogast, S. (2019) · theses.fr (ABES) · doi:10.70675/6915e632z663fz4caaz9c7az455ad25755da
Wagner, M. (2019) · theses.fr (ABES) · doi:10.70675/22404981zcf3cz47ffzbfb7z3ed36606f44e · Cited by 2
Exposition aux endotoxines : influence de l'alimentation et rôle dans le vieillissement cognitif
André, P. (2020) · theses.fr (ABES) · doi:10.70675/ea1360c2zd962z46f5zaabfzcbc15c0efc25
Huang, Y., Li, Q., Chen, A., Li, Y., Chuang, Y.-N., Hu, X., Guo, S. J., He, X., Pang, Y., Zhou, J., et al. (2026) · JAMIA Open · doi:10.1093/jamiaopen/ooag060 · Cited by 2
Riahi, R., Mansournia, M. A., Badihian, N., & Hosseini, S. M. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045217
Kang, S., Ebbels, T. M. D., Chan, Q. M., Whiley, L., Holmes, E. C., Yaffe, K. S., Meyer, K., & Griffin, J. L. (2026) · Metabolomics · doi:10.1007/s11306-026-02458-w · Cited by 1
“The significant NMR-detected metabolites in the total multivariate model included valine, which showed a positive association with WC, and glycine, which showed a negative association with fasting glucose ( p 0.05, Table 2 [1]).”
InfluentialKearley, J., Rajagopal, C., LoParco, S., Bhaskara, M. R., Uddin, L. Q., Mišić, B., Einstein, G., Pilote, L., & Rajah, M. N. (2026) · Research Square · doi:10.21203/rs.3.rs-10157591/v1
Gostyńska, A., Posadzy-Małaczyńska, A., Kruszyńska, N., Romanowska, M., Puszcz, A., Piesiak, K., Konopelski, T., & Ostrowska, B. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197391
“…association between total cholesterol and cognitive scores in older adults aligns with wider epidemiological syntheses, including the meta-analysis by Wee et al. (2023) [4] encompassing over 1.2 million individuals and the longitudinal findings of Anstey et al. (2017) [23] in 23,338 participants.”
InfluentialHeart and Brain: Linking Obesity-Related Inflammation, Cardiovascular Disease and Cognitive Function
Reiss, A. B., Gulkarov, S., Syed, U., Ben-Dor, G. A., Srivastava, A., Singh, M., & Leon, J. D. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13100477
“The relationship between peripheral lipid levels and cognitive decline is complex and may vary with age, but lipid dysregulation remains a plausible pathway linking obesity to vascular cognitive impairment and neurodegeneration [152,154].”
Malcampo, M., Hernáez, Á., Hernando‐Redondo, J., Ros, E., Corella, D., Martínez‐González, M. Á., Salas‐Salvadó, J., Estruch, R., Timiraos, J., Gómez‐Gracia, E., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209197
Gau, S.-Y., Lo, S., HSU, C., Tu, Y.-F., Su, Y.-J., Chen, C.-C., Wu, M.-C., Mitsukura, Y., & Chang, H.-C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1942691
Metadata
- Authors
- Anstey, K. J., Ashby-Mitchell, K., & Peters, R.
- Affiliations
- Australian National University (AU)
- Corresponding author
- Anstey, Kaarin J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-11-29
- Volume
- 56
- Issue
- 1
- Pages
- 215-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5240556
- OpenAlex
- W2558803774
- Semantic Scholar
- 0c1251803f118cf5e382bfc6624ab0fbd3c53d8f
- Cited by
- 360
- References
- 61
- Citations by year
- 2026: 18 · 2025: 42 · 2024: 52 · 2023: 43 · 2022: 52 · 2021: 51 · 2020: 43 · 2019: 34 · 2018: 18 · 2017: 7
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- ANU Open Research (Australian National University) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Research (PDF-2012-05-197)
- National Health and Medical Research Council (1002560)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- serum cholesterol
- MeSH terms
- Alzheimer Disease, Cholesterol, Dementia, Humans, Risk Factors, Cohort Studies, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
